Return to search

Successful management of chylothorax with etilefrine: case report in 2 pediatric patients

El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado. / Chylothorax is defined as the accumulation of chyle within the pleural space. Originally described in 1917 by Pisek, it is the most common cause of pleural effusion in the neonatal period. The leading cause of chylothorax is laceration of the thoracic duct during surgery, which occurs in 0.85% to 6.6% of children undergoing cardiothoracic surgery. Few authors of reports in the literature have looked at etilefrine, a relatively unknown sympathomimetic, as an option for the medical treatment of chylothorax. In this case report, we review the clinical course of 2 infants with type III esophageal atresia who developed chylothorax after thoracic surgery and were successfully treated with intravenous etilefrine after failing initial dietary and pharmacological management. / Revisión por pares

Identiferoai:union.ndltd.org:PERUUPC/oai:repositorioacademico.upc.edu.pe:10757/624655
Date05 1900
CreatorsMuniz, Gysella, Hidalgo-Campos, Jennifer, Valdivia-Tapia, Maria del Carmen, Shaikh, Nader, Carreazo, Nilton Yhuri
Contributorsyhuroc@gmail.com
PublisherAmerican Academy of Pediatrics
Source SetsUniversidad Peruana de Ciencias Aplicadas (UPC)
LanguageEnglish
Detected LanguageEnglish
Typeinfo:eu-repo/semantics/article
Formatapplication/pdf
SourceUniversidad Peruana de Ciencias Aplicadas (UPC), Repositorio Academico - UPC, Pediatrics, 141, 5, e20163309
Rightsinfo:eu-repo/semantics/restrictedAccess
Relationhttp://pediatrics.aappublications.org/lookup/doi/10.1542/peds.2016-3309

Page generated in 0.0019 seconds